Program Description CAR T-cell therapy for multiple myeloma continues to rapidly evolve, reshaping the treatment landscape. Hematology/oncology healthcare professionals especially clinicians in the community setting are challenged to stay ahead of the latest data, emerging CAR T therapies, and real-world evidence, making expert guidance essential. This engaging online program brings together renowned multiple myeloma experts Luciano Costa, MD, PhD, Binod Dhakal, MD, and Michael Bishop, MD, to translate cutting-edge research and real-world findings into practical strategies that you can apply immediately in your practice. The program explores the expanding role of CAR T therapies, emerging CAR T therapies including therapies with novel targets and mechanisms of action new evidence on optimal sequencing and selection, best practices for adverse-event monitoring and management, and opportunities and challenges for CAR T therapy in the outpatient and community setting. Designed to elevate confidence and close persistent practice gaps, this program empowers clinicians to make informed, evidence-based decisions that can meaningfully improve patient outcomes.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- Haymarket Medical Education
Pricing
82% of listed courses are free
78 of 95 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Preventive Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.5 credits
- Commercial Support
-
ReleasedJan 16, 2026
-
Last day to claim creditJan 17, 2027 3 months left
-
Integritas Communications CAR T-cell Therapy in MM Dialogue Between a MM Expert and a Community Oncologist
-
Plexus Communications +1 Beyond BCMA: Exploring GPRC5D-Directed CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma
-
Catalyst Medical Education, LLC +1 Navigating the Bridge to CAR-T: Conversations and Cases on Individualized Bridging Strategies
-
Haymarket Medical Education The Promise of Emerging CAR Ts in RRMM: Strategies to Improve Adoption in the Community
-
Haymarket Medical Education EXPERT PERSPECTIVE #1 The Evolving Role of CAR-T Therapy in RRMM: Access and Evidence
-
Haymarket Medical Education CAR T-Cell Therapy for NHL: Empowering APPs to Advance Patient Care
